U.S. Markets open in 8 hrs 46 mins

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
0.67+0.02 (+3.08%)
At close: 3:59PM EDT
Full screen
Previous Close0.65
Open0.65
Bid0.65 x 0
Ask0.67 x 0
Day's Range0.63 - 0.67
52 Week Range0.19 - 1.13
Volume280,880
Avg. Volume186,984
Market Cap93.42M
Beta2.40
PE Ratio (TTM)-5.00
EPS (TTM)-0.13
Earnings DateMay 4, 2017 - May 8, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.19
  • Zacks Small Cap Research2 days ago

    Oncolytics’ (ONCYF) End of Phase II Meeting

    By John Vandermosten, CFA OTC:ONCYF TSX:ONC.V Oncolytics Biotech (OTC:ONCYF) (TSX:ONC.TO) announced a successful end of Phase II meeting with the FDA in a September 18 press release.  The purpose of the ...

  • PR Newswire3 days ago

    Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers Conference

    CALGARY and SAN DIEGO, Sept. 19, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (ONC.TO) (ONCYF) (Oncolytics or the Company), a biotech company developing REOLYSIN®, a first-in-class, intravenously delivered immuno-oncolytic virus that activates the innate and adaptive immune systems, today announced that it will present at the Phacilitate Immuno-Oncology Frontiers Conference.  Dr. Andres Gutierrez, Oncolytics' Chief Medical Officer, will present at 4:00 pm CEST on September 21, 2017 at the Maritim Proarte Hotel. The conference takes place on September 20th and 21st in Berlin, Germany.

  • CNW Group3 days ago

    Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers Conference

    Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers Conference